"Apparently, you can only be treated once": A qualitative study exploring perceptions of hepatitis C and access to treatment among people who inject drugs visiting a needle and syringe program
Authors: Fontaine G, Presseau J, Bruneau J, Patey AM, van Allen Z, Mortazhejri S, Høj SB, Hung JC, Grimshaw JM
Journal: Liver International
A road map to viral hepatitis elimination in BC by 2030
Authors: Bartlett SR, Schmitz D, Harnest J, Duddy J, Lee M
Journal: BC Medical Journal
Association of MASLD Phenotypes with Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk Factors
Authors: Wesal Elgretli, Mohamed Shengir, Solomon Sasson, Agnihotram V. Ramanakumar, Felice Cinque, Luz Esther Ramos Ballestreros, Marc Deschenes, Phil Wong, Tianyan Chen, Nadine Kronfli, Sahar Saeed, Alexa Keeshan, Saniya Tandon, Curtis Cooper, Giada Sebastiani
Journal: Journal of Viral Hepatitis
Bridging Hepatitis C Care Gaps: A Modeling Approach for Achieving the WHO's Targets in Ontario, Canada
Authors: Sahakyan Y, Erman A, Wong WWL, Greenaway C, Janjua N, Kwong JC, Sander B.
Journal: Viruses
Coordinated expansion of memory T follicular helper and B cells mediates spontaneous clearance of HCV reinfection
Authors: Eisa M, Gomez-Escobar E, Bédard N, Abdeltawab NF, Flores N, Mazouz S, Fieffé-Bédard A, Sakayan P, Gridley J, Abdel-Hakeem MS, Bruneau J, Grakoui A, Shoukry NH
Journal: Front Immunology
DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people
Authors: Gobran ST, Pagliuzza A, Khedr O, Fert A, Chomont N, Bruneau J, Klein MB, Ancuta P, Shoukry NH
Journal: Journal of Virology
Feasibility of hepatitis C elimination by screening and treatment alone in high-income countries
Authors: Tian F, Forouzannia F, Feng Z, Biondi M, Mendlowitz A, Feld J, Sander B, Wong W.W.L.
Journal: Hepatology
Frequent disengagement and subsequent mortality among people living with HIV and Hepatitis C in Canada: A prospective cohort study
Authors: Saeed S, Thomas T, Dinh D, Moodie EEM, Cox J, Cooper C, Gill MJ, Martel-Laferriere V, Panagiotoglou D, Walmsley S, Wong A, Klein MB
Journal: Open Forum Infectious Diseases
GRAND PLAN: Safety and Efficacy of Glecaprevir/Pibrentasvir for the Treatment of Hepatitis C Virus Infection Among People Initially Disengaged From Health Care Who Use Drugs-A Systematic Multidisciplinary Approach
Authors: Conway, B., Yi, S., Yung, R. & Sharma, S.
Journal: Open Forum Infectious Diseases
Impact of new direct direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection in Canada
Authors: Forouzannia F, Hamadeh A, Passos-Castilho AM, Erman A, Yu A, Feng Z, Janjua N, Sander B, Greenaway C, Wong W.W.L.
Journal: Liver International
Impact of the COVID-19 pandemic on hepatitis C treatment initiation in British Columbia, Canada: an interrupted time series study
Authors: Morrow R, Binka M, Li J, Irvine M, Bartlett S, Wong S, Jeong D, Makuza JD, Wong J, Yu A, Krajden M, Janjua NZ
Journal: Viruses
Mixed-Genotype HCV Direct Acting Antiviral Outcomes: a CANUHC Analysis
Authors: Imsirovic H, Macphail G, Conway B, Fraser C, Borgia S, Smyth D, Wong A, Vachon M-L, Webster D, Liu H, Feld J, Lee S, Cooper C
Journal: Journal of Viral Hepatitis
Modeling the impact of a supervised consumption site on HIV and HCV transmission among people who inject drugs in three counties in California, USA
Authors: Bartlett SR, Schmitz D, Harnest J, Duddy J, Lee M
Journal: International Journal of Drug Policy
Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study
Authors: Passos-Castilho AM, Murphy DG, Blouin K, Benedetti A, Panagiotoglou D, Bruneau J, Klein MB, Kwong JC, Sander B, Janjua NZ, Greenaway C
Journal: Viruses
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria
Authors: Pennisi G, Enea M, Romero-Gomez M, Bugianesi E, Wong Wai-Sun V, Fracanzani AL, De Ledinghen V, George J, Berzigotti A, Vigano M, Sebastiani G, Cannella R, Delamarre A, Di Maria G, Lange NF, Tulone A, Di Marco V, Camma C, Petta S
Journal: Hepatology
Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis
Authors: Levinsson A, Zolopa C, Vakili F, Udhesister S, Kronfli N, Maheu-Giroux M, Bruneau J, Valerio H, Bajis S, Read P, Martró E, Boucher L, Morris L, Grebely J, Artenie A, Stone J, Vickerman P, Larney S
Journal: eClinical Medicine (PArt of Lancet Discovery Science)
The impact of the COVID-19 pandemic on social determinants of health, mental health, and substance use among key populations affected by sexually transmitted and blood-borne infections in Canada
Authors: Apelian H, Aho J, Wong E, Cox J
Journal: Canadian Journal of Public Health
Trends in toxicological findings in unintentional opioid or stimulant toxicity deaths in Québec, Canada, 2012-2021: Has Québec entered a new era of drug-related deaths
Authors: Do U, Perron PA, Bruneau J, Larney S
Journal: Drugs and Alcohol Review
Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: a qualitative study among people who inject drugs and service providers
Authors: Fontaine G, Presseau J, Bruneau J, Etherington C, Thomas IM, Hung JC, van Allen Z, Patey AM, Kareem A, Mortazhejri S, Høj SB, Boyer-Legault G, Grimshaw JM
Journal: International Journal for Equity in Health
Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada
Authors: Greenwald ZR, Werb D, Feld JJ, Austin P, Fridman D, Bayoumi AM, Gomes T, Kendall C, Lapointe-Shaw L, Scheim AI, Bartlett S, Benchimol EI, Bouck Z, Boucher L, Greenaway C, Janjua NZ, Leece P, Wong WWL, Sander B, Kwong JC
Journal: Journal of Clinical Epidemiology
Postal address
University Health Network
Toronto General Hospital
200 Elizabeth Street, 9EB-240
Toronto (ON) M5G 2C4
CanHepC's administrative office is situated on the traditional territories of the Mississaugas of the Credit, the Anishnabeg, the Haudenosaunee and the Wendat peoples. Toronto is covered by Treaty 13 with the Mississaugas of the Credit.
© 2025 CanHepC - Canadian Network on Hepatitis C. All Rights Reserved.
